A Catalytic Osmium Redox Couple Collapses Cancer Redox Balance
Advanced Science · 2026-08 · 13 (43)
DOI: 10.1002/advs.75576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.05.2026. Verfasst von Wan-Qiong Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, P. R. China. Hauptthemen laut MEDLINE: Osmium, Reactive Oxygen Species, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Key (Guangdong-Hong Kong Joint) Laboratory for Preparation and Application of Ordered Structural Materials of Guangdong Province, Hong Kong Research Grants Council.
Abstract (Originalsprache)
Developing agents that disrupt the redox balance of tumor cells by simultaneously increasing reactive oxygen species (ROS) and decreasing antioxidants offers a promising approach in chemotherapy. Here, we present an isolable, interconvertible osmium redox pair, trans ‐[Os III (NHPPh 3 )(L)(4‐Me 2 Npy)] + and trans ‐[Os IV (NHPPh 3 )(L)(4‐Me 2 Npy)] 2 + [ Os(III) and Os(IV) ]. This self‐sustaining redox cycle of Os(III) and Os(IV) exhibit dual‐mode catalytic activity, experimental results show that Os(III) catalyses Fenton‐like activation of H 2 O 2 to produce hydroxyl radicals, whereas Os(IV) oxidizes GSH to GSSG, regenerating Os(III) within cells. This cycle disrupts cellular redox homeostasis, prompting apoptosis and ferroptosis, and displays features of immunogenic cell death. In vivo, both Os(III) and Os(IV) inhibit tumor growth with good tolerability and enhance antitumor immune responses. These findings position redox‐cycling metal complexes as a promising strategy to target cancer redox vulnerabilities, encouraging further exploration of combination therapies with immunotherapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, P. R. China.
- Department of Medicinal Chemistry, Shantou University Medical College, Shantou, Guangdong, P. R. China.
- Department of Chemistry, Hong Kong Baptist University, Kowloon, HKSAR, P. R. China.
- Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, P. R. China.
ORCID-Profile: Wai-Lun Man, Wen-Xiu Ni
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Key (Guangdong-Hong Kong Joint) Laboratory for Preparation and Application of Ordered Structural Materials of Guangdong Province
- Hong Kong Research Grants Council
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Huang, W. Q., Huang, T., Hao, Y., Huang, G. F., Yan, Y. L., Fang, X., Chen, Y., Wei, X. L., Man, W. L., & Ni, W. X. (2026). A Catalytic Osmium Redox Couple Collapses Cancer Redox Balance. Advanced Science, 13(43). https://doi.org/10.1002/advs.75576
Vancouver
Huang WQ, Huang T, Hao Y, Huang GF, Yan YL, Fang X, et al. A Catalytic Osmium Redox Couple Collapses Cancer Redox Balance. Advanced Science. 2026;13(43). doi:10.1002/advs.75576
BibTeX
@article{Huang2026,
author = {Huang, Wan-Qiong and Huang, Tao and Hao, Yiming and Huang, Gui-Feng and Yan, Yi-Lang and Fang, Xin and Chen, Ying and Wei, Xiao-Long and Man, Wai-Lun and Ni, Wen-Xiu},
title = {A Catalytic Osmium Redox Couple Collapses Cancer Redox Balance},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {43},
doi = {10.1002/advs.75576}
}
EUVIMED